Research and development expenses in the third quarter of 2022 were $24.2 million, an increase from $20.6 million in the third quarter of 2021. Research and development expenses in the third quarter of 2022 included $3.2 million attributable to share-based compensation compared to $3.7 million in the third quarter of 2021.
Innoviz maintains a high liquidity level with approximately $218 million in cash, short term deposits, short term restricted cash and marketable securities as of September 30, 2022.
Guidance
Innoviz reaffirms the following 2022 guidance it has previously provided:
- The Company has achieved its stated goal of winning at least one new series production award in 2022, and to date has delivered two.
- The Company expects to increase its forward-looking order book by more than 30% by the end of 2022 and has already delivered a 165% increase year to date.
- The Company has achieved its expected stated goal to secure 10 pre-production programs during 2022. To date, the Company has participated in 14.
Conference Call
Innoviz management will hold a web conference today, November 9, 2022, at 9:00 a.m. Eastern time (6:00 a.m. Pacific time) to discuss these results. Innoviz CEO Omer Keilaf and CFO Eldar Cegla will host the call, followed by a question-and-answer session.
Investors are invited to attend by registering in advance here. All relevant information will be sent upon registration.
A replay of the webinar will also be available shortly after the call in the Investors section of Innoviz's website for 90 days.
About Innoviz Technologies
Innoviz is a global leader in LiDAR technology, working towards a future with safe autonomous vehicles on the world's roads. Innoviz's LiDAR and perception software "see" better than a human driver and reduce the possibility of error, meeting the automotive industry's strictest expectations for performance and safety. Operating across the U.S., Europe, and Asia, Innoviz has been selected by internationally recognized premium car brands for use in consumer vehicles as well as by other commercial and industrial leaders for a wide range of use cases. For more information, visit www.innoviz-tech.com
Join the discussion: Facebook, LinkedIn, YouTube, Twitter
Media Contact
Investor Contact (US) Investor Contact (Israel)
Rob Moffatt Maya Lustig
VP, Corporate Development & IR Director, Investor Relations
Innoviz Technologies Innoviz Technologies
+1 (203) 665-8644 +972 54 677 8100
Email Contact
Email Contact
Forward Looking Statements
This announcement contains certain forward-looking statements within the meaning of the federal securities laws, including statements regarding the services offered by Innoviz, the anticipated technological capability of Innoviz's products, the markets in which Innoviz operates, Innoviz's forward-looking order book, and Innoviz's projected future results. These forward-looking statements generally are identified by the words "believe," "project," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result," and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. "Forward-looking order book" is the cumulative projected future sales of hardware and perception software based on current estimates of volumes and pricing relating to a project. Many factors could cause actual future events, and, in the case of our forward-looking order book, actual orders, to differ materially from the forward-looking statements in this announcement including but not limited to, the ability to implement business plans, forecasts, and other expectations, the ability to convert design wins into definitive orders and the magnitude of such orders, the ability to identify and realize additional opportunities, and potential changes and developments in the highly competitive LiDAR technology and related industries. The foregoing list is not exhaustive. You should carefully consider such risk and the other risks and uncertainties described in Innoviz's annual report on Form 20-F filed with the SEC on March 30, 2022 and other documents filed by Innoviz from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Innoviz assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Innoviz gives no assurance that it will achieve its expectations.
INNOVIZ TECHNOLOGIES LTD. AND ITS SUBSIDIARIES | ||||||||
CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||||
U.S. dollars in thousands (except share and per share data) | ||||||||
| ||||||||
|
| Nine Months Ended |
| Three Months Ended | ||||
|
| September 30, |
| September 30, | ||||
|
| 2022 |
| 2021 |
| 2022 |
| 2021 |
|
| (Unaudited) |
| (Unaudited) | ||||
|
|
|
|
|
|
|
|
|
Revenues | $ | 4,449 | $ | 3,811 | $ | 878 | $ | 2,076 |
Cost of revenues |
| (10,677) |
| (5,737) |
| (4,593) |
| (2,201) |
|
|
|
|
|
|
|
|
|
Gross loss |
| (6,228) |
| (1,926) |
| (3,715) |
| (125) |
|
|
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
Research and development |
| 68,862 |
| 69,397 |
| 24,162 |
| 20,576 |
Selling and marketing |
| 7,875 |
| 20,834 |
| 2,494 |
| 3,652 |
General and administrative |
| 14,341 |
| 30,179 |
| 4,597 |
| 5,753 |
|
|
|
|
|
|
|
|
|
Total operating expenses |
| 91,078 |
| 120,410 |
| 31,253 |
| 29,981 |
|
|
|
|
|
|
|
|
|
Operating loss |
| (97,306) |
| (122,336) |
| (34,968) |
| (30,106) |
|
|
|
|
|
|
|
|
|
Financial income, net |
| 4,852 |
| 2,827 |
| 812 |
| 3,735 |
|
|
|
|
|
|
|
|
|
Loss before taxes on income |
| (92,454) |
| (119,509) |
| (34,156) |
| (26,371) |
Taxes on income |
| (97) |
| (132) |
| (49) |
| (60) |
|
|
|
|
|
|
|
|
|
Net loss | $ | (92,551) | $ | (119,641) | $ | (34,205) | $ | (26,431) |
|
|
|
|
|
|
|
|
|
Basic and diluted net loss per ordinary share | $ | (0.69) | $ | (1.35) | $ | (0.25) | $ | (0.20) |
|
|
|
|
|
|
|
|
|
Weighted average number of ordinary shares used
|
| 134,939,362 |
| 92,115,826 |
| 135,602,409 |
| 133,430,689 |
|